Program for Lung and Vascular Biology, Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois; Division of Critical Care, Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois; Department of Pharmacology, University of Illinois College of Medicine, Chicago, Illinois.
Department of Pharmacology, University of Illinois College of Medicine, Chicago, Illinois; Department of Medicine, University of Chicago, Chicago, Illinois.
Am J Pathol. 2019 Aug;189(8):1664-1679. doi: 10.1016/j.ajpath.2019.04.014. Epub 2019 May 20.
Endothelial barrier dysfunction is a central factor in the pathogenesis of persistent lung inflammation and protein-rich edema formation, the hallmarks of acute respiratory distress syndrome. However, little is known about the molecular mechanisms that are responsible for vascular repair and resolution of inflammatory injury after sepsis challenge. Herein, we show that hypoxia-inducible factor-1α (HIF-1α), expressed in endothelial cells (ECs), is the critical transcriptional factor mediating vascular repair and resolution of inflammatory lung injury. After sepsis challenge, HIF-1α but not HIF-2α expression was rapidly induced in lung vascular ECs, and mice with EC-restricted disruption of Hif1α (Hif1a/Tie2Cre) exhibited defective vascular repair, persistent inflammation, and increased mortality in contrast with the wild-type littermates after polymicrobial sepsis or endotoxemia challenge. Hif1a/Tie2Cre lungs exhibited marked decrease of EC proliferation during recovery after sepsis challenge, which was associated with inhibited expression of forkhead box protein M1 (Foxm1), a reparative transcription factor. Therapeutic restoration of endothelial Foxm1 expression, via liposomal delivery of Foxm1 plasmid DNA to Hif1a/Tie2Cre mice, resulted in reactivation of the vascular repair program and improved survival. Together, our studies, for the first time, delineate the essential role of endothelial HIF-1α in driving the vascular repair program. Thus, therapeutic activation of HIF-1α-dependent vascular repair may represent a novel and effective therapy to treat inflammatory vascular diseases, such as sepsis and acute respiratory distress syndrome.
内皮屏障功能障碍是持续性肺部炎症和富含蛋白水肿形成(急性呼吸窘迫综合征的标志)发病机制中的一个核心因素。然而,人们对于在脓毒症后负责血管修复和炎症损伤消退的分子机制知之甚少。在此,我们表明,血管内皮细胞(EC)中表达的缺氧诱导因子-1α(HIF-1α)是介导血管修复和炎症性肺损伤消退的关键转录因子。在脓毒症后,肺血管 EC 中迅速诱导表达 HIF-1α,但不是 HIF-2α,而与野生型同窝仔相比,内皮细胞特异性敲除 Hif1α(Hif1a/Tie2Cre)的小鼠在多微生物脓毒症或内毒素血症后表现出血管修复缺陷、持续性炎症和死亡率增加。Hif1a/Tie2Cre 肺在脓毒症后恢复过程中观察到 EC 增殖明显减少,这与修复转录因子叉头框蛋白 M1(Foxm1)的表达受抑制有关。通过将 Foxm1 质粒 DNA 包裹在脂质体中递送至 Hif1a/Tie2Cre 小鼠,从而恢复内皮细胞 Foxm1 的表达,可导致血管修复程序重新激活,并提高生存率。总之,我们的研究首次描绘了内皮 HIF-1α 在驱动血管修复程序中的重要作用。因此,激活 HIF-1α 依赖性血管修复可能代表治疗炎症性血管疾病(如脓毒症和急性呼吸窘迫综合征)的一种新的有效治疗方法。